Newly approved clot-busting drug works as well as traditional drug for stroke, research shows
A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a ...
Becker's Hospital Review1d
New stroke drug compares favorably to decades-old treatment: Study
The study, published March 12 in JAMA Network Open, compared the newly approved tenecteplase in a single quick injection to alteplase, the stroke treatment that has been used for decades and requires ...
The Cardiology Advisor2d
TNKase Approved for Treatment of Acute Ischemic Stroke
The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.
Psychiatry Advisor1d
FDA Approves TNKase for Acute Ischemic Stroke
The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent.
EMS17d
FDA approves clot-dissolving agent for treatment of acute ischemic stroke
TNKase — tenecteplase — is the first FDA-approved stroke medicine in nearly 30 years, offering a faster, simpler five-second ...
Medical Device Network on MSN1d
FDA clears Perfuze’s Zipline access catheter for stroke treatment
Coinciding with the FDA’s clearance for the catheter, Perfuze has also completed a €22m ($24m) financing round.
WebMD10d
FDA Approves New Treatment for Stroke
The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.
Endovascular Today1d
Perfuze Zipline Access Catheters Cleared by FDA
Perfuze, an Ireland-based developer of catheter-based aspiration technology for the treatment of acute ischemic stroke, ...
Physician's Weekly4d
Emergency Dispatch Stroke Recognition and Impact on Treatment Times
The following is a summary of “Reducing time delays and enhancing reperfusion eligibility related to stroke suspicion by the ...
Fierce Pharma11d
Roche gains label expansion for heart attack medicine TNKase to treat acute ischemic stroke
Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...
Healio10d
FDA approves TNKase for acute ischemic stroke in adults
The FDA has approved TNKase, a tissue plasminogen, clot-dissolving agent, to treat acute ischemic stroke in adults, according ...
Monthly Prescribing Reference11d
TNKase Approved for Treatment of Acute Ischemic Stroke
TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS ...